Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03244267 · ClinicalTrials.gov registry record · NA
App Reminder on ASA Adherence
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 195
- Enrollment target
NCT03244267: Completed NA study, sponsored by Emory University.
NCT03244267 is a NA study that has completed, run by Emory University. The registered enrollment target is 195 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03244267, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 195 participants
- Enrollment target
Study Summary
The purpose of this study is to explore the impact of using a smartphone app reminder on medication adherence twice daily in adults prescribed 81 milligrams of aspirin for 35 days as anti-thrombotic therapy after knee or hip arthroplasty. This study will randomly assign participants to get usual postoperative care which is teaching with verbal instructions and printed information about taking the aspirin at the time of discharge, or to have an app on your smartphone with preset reminders in addition to usual postoperative discharge teaching after surgery.
Primary Outcome
The proportion of pills taken is defined as the percentage of pills taken by study participants.
Interventions
- BEHAVIORAL Standard Education
- BEHAVIORAL Medication Reminder App
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 195 participants |
| Start Date | 2017-10-03 |
| Est. Completion | 2019-03-08 |
| Phase | NA |
What the finished NCT03244267 record still lists
NCT03244267 is an interventional study that assigns participants to a tested intervention. The registered 195 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 2 interventions - of which Standard Education is the first listed.
NCT03244267 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03244267 about?
NCT03244267 is a clinical study titled "App Reminder on ASA Adherence". The purpose of this study is to explore the impact of using a smartphone app reminder on medication adherence twice daily in adults prescribed 81 milligrams of aspirin for 35 days as anti-thrombotic therapy after knee or hip arthroplasty. This study will randomly assign participants to get usual po...
What is the current status of trial NCT03244267?
This trial is currently completed. It is a NA study. The enrollment target is 195 participants. The study started on 2017-10-03. Estimated completion is 2019-03-08.
What interventions are being tested in trial NCT03244267?
The interventions under investigation include: Standard Education (BEHAVIORAL), Medication Reminder App (BEHAVIORAL).
Who is sponsoring clinical trial NCT03244267?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03244267's enrollment target sits among peer trials
195 567th of 2000 higher than 1,433 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04276922 · 195 participants · NA
Creative Arts Program to Reduce Burnout in Healthcare Professionals
- NCT04829357 · 195 participants
Post Market Clinical Follow-up Study on TVT ABBREVO® Continence System
- NCT05054738 · 195 participants · NA
CRP and S&A for Inpatient Veterans
- NCT05561595 · 195 participants · NA
Transdiagnostic Intervention to Reduce Internalized Health-Related Stigma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI